New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
10:51 EDTNYCB, IPG, MHFI, APRIHigh option volume stocks: IPG VXZ APRI MHFI NYCB
News For IPG;APRI;MHFI;NYCB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
07:20 EDTNYCBNew York Community Bancorp reports Q4 EPS 32c, consensus 27c
Subscribe for More Information
January 28, 2015
11:05 EDTMHFIS&P nears $1.37B settlement with states, DOJ, WSJ reports
Subscribe for More Information
10:34 EDTMHFIS&P nearing $1.37B settlement with states and DOJ, DJ reports
Dow Jones cites sources, who say a settlement could be announced as soon as tomorrow.
January 27, 2015
16:34 EDTAPRIApricus Biosciences announces issuance of U.S. patent for RayVa
Apricus Biosciences announced that , January 27, 2015, the United States Patent and Trademark Office, USPTO, issued to Apricus, U.S. Patent No. 8,940,794, titled "METHODS AND COMPOSITIONS FOR TREATING RAYNAUD'S DISEASE," with claims generally directed to methods for treating Raynaud's phenomenon, that is secondary to systemic sclerosis. The patent is expected to expire no earlier than its twenty-year term in 2032. RayVa is the proprietary name for Apricus' product candidate for the treatment of Raynaud's phenomenon. Raynaud's phenomenon is a circulatory disorder affecting the hands and feet. Raynaud's phenomenon secondary to systemic sclerosis affects an estimated three to five percent of people in the U.S., disproportionately affecting women and currently has no approved therapy in the U.S., representing an unmet medical need. The FDA has indicated that Apricus' RayVa product may qualify for priority review, given the unmet medical need and lack of approved products to treat secondary Raynaud's phenomenon. The FDA will determine if the RayVa New Drug Application qualifies for priority review following its submission, which could occur as early as 2017.
15:35 EDTNYCBNotable companies reporting before tomorrow's open
Subscribe for More Information
January 26, 2015
15:14 EDTNYCBNew York Community Bancorp moves Q4 earnings release to January 29
Subscribe for More Information
January 21, 2015
11:02 EDTMHFIS&P near to $1.4B settlement on subprime ratings probe, Bloomberg says
S&P may settle subprime mortgage suits as early as next week, added Bloomberg. The S&P settlement is separate from the SEC probe into CMBS, according to Bloomberg.
10:58 EDTMHFIS&P near to $1.4B settlement on subprime ratings probe, Bloomberg says
Subscribe for More Information
09:12 EDTMHFIS&P Ratings Services reaches settlements with SEC, Attorney Generals of NY, Mass
Subscribe for More Information
09:08 EDTMHFINew York AG joins SEC in settlement with Standard and Poor's
Subscribe for More Information
09:07 EDTMHFIS&P to pay $58M to settle SEC charges
Subscribe for More Information
09:06 EDTMHFISEC announces charges against S&P for fraudulent ratings misconduct
The Securities and Exchange Commission announced a series of federal securities law violations by Standard & Poorís Ratings Services involving fraudulent misconduct in its ratings of certain commercial mortgage-backed securities. S&P agreed to pay more than $58M to settle the SECís charges, plus an additional $19M to settle parallel cases announced by the New York Attorney Generalís office -- $12M -- and the Massachusetts Attorney Generalís office -- $7M. The SEC issued three orders instituting settled administrative proceedings against S&P. One order, in which S&P made certain admissions, addressed S&Pís practices in its conduit fusion CMBS ratings methodology. S&Pís public disclosures affirmatively misrepresented that it was using one approach when it actually used a different methodology in 2011 to rate six conduit fusion CMBS transactions and issue preliminary ratings on two more transactions. As part of this settlement, S&P agreed to take a one-year timeout from rating conduit fusion CMBS. In a separate order instituting a litigated administrative proceeding, the SEC Enforcement Division alleges that the former head of S&Pís CMBS Group fraudulently misrepresented the manner in which the firm calculated a critical aspect of certain CMBS ratings in 2011. Barbara Duka allegedly instituted the shift to more issuer-friendly ratings criteria, and the firm failed to properly disclose the less rigorous methodology. The matter against Duka will be scheduled for a public hearing before an administrative law judge for proceedings to adjudicate the Enforcement Divisionís allegations and determine what, if any, remedial actions are appropriate.
09:05 EDTMHFISEC announves charges against S&P for fraudulent ratings misconduct
Subscribe for More Information
January 20, 2015
15:29 EDTMHFIS&P may pay $1.5B to U.S to settle ratings issue, Reuters says
S&P in talks with U.S. Justice department and individual states over mortgage ratings, Reuters added.
14:43 EDTMHFIS&P said to be banned by SEC on rating some CMBSs for year, Bloomberg reports
Subscribe for More Information
14:16 EDTMHFIS&P said to be banned by SEC on rating some CMBSs for year, Bloomberg reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use